PAQR3 and colorectal carcinoma: Our findings provide novel insights into the molecular mechanisms underlying the progression of CRC and suggest that targeting PAQR3 or utilizing its mimetic peptide, P6-55, may offer a promising avenue for the development of therapeutic strategies in future research.